Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Early Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Early Phase 1
1 (100.0%)A Feasibility Study to Evaluate the Tolerability of Oph1 Compared to Restasis in Healthy Volunteers
- First Posted Date
- 2022-01-11
- Last Posted Date
- 2024-04-05
- Lead Sponsor
- OphRx Ltd.
- Target Recruit Count
- 20
- Registration Number
- NCT05184517
- Locations
- 🇮🇱
Shaare Zedek Medical Center, Jerusalem, Israel
News
No news found